Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations | Zendy

Michael Zavaski | Zendy; Christian P. Meyer | Zendy; Jesse D. Sammon | Zendy; Julian Hanske | Zendy; Soham Gupta | Zendy; Maxine Sun | Zendy; QuocDien Trinh | Zendy

Open Access

Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations

Author(s) -

Michael Zavaski,

Christian P. Meyer,

Jesse D. Sammon,

Julian Hanske,

Soham Gupta,

Maxine Sun,

QuocDien Trinh

Publication year - 2016

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2015.7901

Subject(s) - medicine , prostate specific antigen , primary care , family medicine , medline , gynecology , prostate , cancer , political science , law

patients relating to their use. In addition, including CAM physicians in groups such as accountable care organizations can improve communication between physicians and streamline patient records.5 Clinical and organizational incentives that encourage patient disclosure of CAM use may facilitate better coordination of care, reduce the risk of adverse interactions between conventional medications and CAM products, and lead to better patient outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research